Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT # 1 - ACCENTIA BIOPHARMACEUTICALS INC | d87698ds1a.htm |
| EX-23.1 - CONSENT OF CHERRY, BEKAERT & HOLLAND, LLP - ACCENTIA BIOPHARMACEUTICALS INC | d87698dex231.htm |
Exhibit 21
Accentia Biopharmaceuticals, Inc. (“Accentia”) has three direct and indirect subsidiaries:
| 1. | Accentia holds all of the issued and outstanding equity securities of TEAMM Pharmaceuticals, Inc. d/b/a Accentia Pharmaceuticals, a Florida corporation. |
| 2. | Accentia holds all of the issued and outstanding equity securities of Accentia Biotech, Inc. f/k/a Analytica International, Inc., a Florida corporation. |
| 3. | Accentia holds 61% of the issued and outstanding equity securities of Biovest International, Inc., a Delaware corporation. |